Extracellular Vesicles from Nanomedicine‐Trained Intestinal Microbiota Substitute for Fecal Microbiota Transplant in Treating Ulcerative Colitis
Advanced Materials · 2024
DOI: 10.1002/adma.202409138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Menghang Zu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Fecal Microbiota Transplantation, Gastrointestinal Microbiome, Extracellular Vesicles. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Venture & Innovation Support Program for Chongqing Overseas Returnees.
Abstract (Originalsprache)
The biosafety concerns associated with fecal microbiota transplant (FMT) limit their clinical application in treating ulcerative colitis (UC). Gut microbiota secrete abundant extracellular vesicles (Gm‐EVs), which play a critical role in bacteria‐to‐bacteria and bacteria‐to‐host communications. Herein, intestinal microbiota are trained using tea leaf lipid/pluronic F127‐coated curcumin nanocrystals (CN@Lp 127 s), which can maintain stability during transit through the gastrointestinal tract. Compared with FMT, Gm‐EVs derived from healthy mice significantly improve treatment outcomes against UC by reducing colonic inflammatory responses, restoring colonic barrier function, and rebalancing intestinal microbiota. Strikingly, Gm‐EVs obtained from CN@Lp 127 ‐trained healthy mice exhibit a superior therapeutic effect on UC compared to groups receiving FMT from healthy mice, Gm‐EVs from healthy mice, and FMT from CN@Lp 127 ‐trained healthy mice. Oral administration of Gm‐EVs from CN@Lp 127 ‐trained healthy mice not only alleviates colonic inflammation, promotes mucosal repair, and regulates gut microbiota but also regulates purine metabolism to decrease the uric acid level, resulting in a robust improvement in the UC. This study demonstrates the UC therapeutic efficacy of Gm‐EVs derived from nanomedicine‐trained gut microbiota in regulating the immune microenvironment, microbiota, and purine metabolism of the colon. These EVs provide an alternative platform to replace FMT as a treatment for UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and…
- State Key Laboratory of Resource Insects, College of Sericulture, Textile, and Biomass Sciences, Southwest University, Chongqing, 400715, China.
- Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
- School of Life Sciences, Southwest University, Chongqing, 400715, China.
- Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, Groningen, 9713 AV, Netherlands.
- W.J. Kolff Institute for Biomedical Engineering and Materials Science, University of Groningen, Antonius Deusinglaan 1, Groningen, 9713 AV, Netherlands.
ORCID-Profile: Bo Xiao
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Venture & Innovation Support Program for Chongqing Overseas Returnees
- Science Fund for Distinguished Young Scholars of Chongqing Municipality
- Key Science and Technology Research Project in Jiangxi Province Department of Education
Zitieren
APA
Zu, M., Liu, G., Xu, H., Zhu, Z., Zhen, J., Li, B., Shi, X., Shahbazi, M. A., Reis, R. L., Kundu, S. C., Nie, G., & Xiao, B. (2024). Extracellular Vesicles from Nanomedicine‐Trained Intestinal Microbiota Substitute for Fecal Microbiota Transplant in Treating Ulcerative Colitis. Advanced Materials. https://doi.org/10.1002/adma.202409138
Vancouver
Zu M, Liu G, Xu H, Zhu Z, Zhen J, Li B, et al. Extracellular Vesicles from Nanomedicine‐Trained Intestinal Microbiota Substitute for Fecal Microbiota Transplant in Treating Ulcerative Colitis. Advanced Materials. 2024. doi:10.1002/adma.202409138
BibTeX
@article{Zu2024,
author = {Zu, Menghang and Liu, Ga and Xu, Haiting and Zhu, Zhenhua and Zhen, Junfeng and Li, Baoyi and Shi, Xiaoxiao and Shahbazi, Mohammad-Ali and Reis, Rui L and Kundu, Subhas C and Nie, Guangjun and Xiao, Bo},
title = {Extracellular Vesicles from Nanomedicine‐Trained Intestinal Microbiota Substitute for Fecal Microbiota Transplant in Treating Ulcerative Colitis},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202409138}
}
EUVIMED